Delcath Systems, Inc. DCTH

Q2 FY2026 · ended Jun 30, 2026 · Revenue $29.13M, +20.6% YoY · Filed Aug 6, 2026

Delcath Systems, Inc. (DCTH) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $29.1 million and net income of $2.7 million. Free cash flow was $5.2 million. As of Jun 30, 2026 it held $95.9 million in cash and investments and $2.5 million in total debt.

Revenue
$29.13M
+20.6% vs year-ago quarter
Net income
$2.67M
-1.1% vs year-ago quarter
Operating cash flow
$5.71M
-21.7% vs year-ago quarter
Free cash flow
$5.21M
-24.5% vs year-ago quarter
EPS
$0.07
+0.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
34.70M
-0.8% vs year-ago quarter
Net cash
$93.44M
Q2 FY2026
Operating margin
-1.9%
TTM

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
DCTH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Queensbury, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
872912
Former names
DELCATH SYSTEMS, INC. (until Oct 27, 2026); DELCATH SYSTEMS INC (until Apr 22, 2013)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$29.1M
$25.0M
$20.7M
$20.6M
$24.2M
Operating income
$2.4M
-$1.6M
-$2.2M
-$388,000
$2.6M
Net income
$2.7M
-$1.1M
-$1.9M
$830,000
$2.7M
Diluted EPS
$0.07
-$0.03
-$0.05
$0.02
$0.07
Operating cash flow
$5.7M
$857,000
$8.2M
$4.8M
$7.3M
Free cash flow
$5.2M
$287,000
$7.7M
$4.3M
$6.9M
Total assets
$137.0M
$124.8M
$123.6M
$124.3M
$116.9M
Total liabilities
$15.9M
$12.1M
$12.4M
$9.4M
$11.9M
Stockholders' equity
$121.1M
$112.7M
$111.2M
$114.8M
$105.0M
Cash and investments
$95.9M
$89.3M
$91.0M
$88.9M
$81.0M
Total debt
$2.5M
$907,000
$936,000
$965,000
$993,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Bylaw or fiscal year change
Aug 14, 2026 Aug 12, 2026
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 14, 2026 May 13, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.